Nektar Therapeutics | NKTR - Ebitda





Ebitda Changement Date
Agios Pharmaceuticals USD -109.2M 540K 2026-06
ALKERMES USD 120.06M 19.15M 2026-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.8B 1.25B 2026-09
Baxter International USD 474M 165M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 13.88B 154.2M 2026-09
Dr.Reddys Laboratories INR 8.6B 2.14B 2026-06
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Xencor USD 25.1M 59.73M 2026-09